Regeneron Cites Medtronic Ruling In Amgen Bundling Case
Regeneron has told a Delaware federal judge there is new reason to preserve its $407 million win against Amgen over cholesterol drug bundling after a California federal judge found in an...To view the full article, register now.
Already a subscriber? Click here to view full article